WO2008021779A2 - Custom length stent apparatus - Google Patents
Custom length stent apparatus Download PDFInfo
- Publication number
- WO2008021779A2 WO2008021779A2 PCT/US2007/075248 US2007075248W WO2008021779A2 WO 2008021779 A2 WO2008021779 A2 WO 2008021779A2 US 2007075248 W US2007075248 W US 2007075248W WO 2008021779 A2 WO2008021779 A2 WO 2008021779A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- separator
- prosthetic segments
- segments
- prosthetic
- fingers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2002/826—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
- A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F2002/9665—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod with additional retaining means
Definitions
- This invention relates generally to medical apparatus and methods, and more specifically to vascular catheters, stents and stent delivery systems for use in the coronary arteries and other vessels.
- Stenting is an important treatment option for patients with vascular occlusive disease.
- the stenting procedure involves placing a tubular prosthesis at the site of a lesion, typically within a diseased coronary artery. The procedure is performed in order to maintain the patency of the artery and is often performed after a primary treatment such as angioplasty.
- a primary treatment such as angioplasty.
- restenosis i.e. the tendency for the stented coronary artery to become re-occluded following implantation of the stent.
- restenosis rates have decreased substantially, due in part to drug eluting stents as well as other improvements in stent delivery methods and stent technology. As a result, the number of stent related procedures being performed worldwide continues to dramatically increase.
- Stents are typically either self-expanding or balloon expandable and they are delivered to the coronary arteries using long, flexible vascular catheters typically inserted percutaneously through the patient ' s femoral artery.
- self-expanding stents the stent is simply released from the delivery catheter and it resiliency expands into engagement with the vessel wall.
- balloon expandable stents a balloon on the delivery catheter is expanded which expands and deforms the stent to the desired diameter, whereupon the balloon is deflated and removed, leaving the stent in place.
- Another challenge with existing "custom length" stent delivery systems is that to deliver multiple stent segments to multiple lesion sites requires an intricate delivery system that can be somewhat complex to use. Thus, a simpler delivery system that allows length customization with fewer prosthetic segments on the delivery catheter is desirable, especially for use in treating a single lesion. It is also desirable to protect stent segments on the delivery system from being improperly displaced, deformed or damaged during delivery and deployment.
- the invention generally provides for the delivery of prosthetic segments with a flexible delivery catheter capable of navigating torturous vessels such as the coronary arteries.
- the delivery catheter permits deployment of a selectable number of prosthetic segments at a single treatment site, thus allowing customization of prosthesis length while the delivery catheter is in a body lumen at a treatment site. Customization of prosthesis length in situ permits better matching of the prosthesis length to the lesion length being treated.
- the delivery catheter has a simplified design including a control mechanism on the catheter handle for selecting prosthetic segments for deployment and a stent valve or separator on the distal end of an outer shaft that facilitates deployment of the selected group of stent segments. A sheath protects the prosthetic segments from damage during delivery and deployment.
- the terms "stent' " and “stenting” are defined to include any of the array of expandable prostheses and scaffolds which are introduced into a lumen at a target treatment site and expanded in situ thereby exerting a radially outward force against the lumen wall.
- the prosthesis of the present invention comprises a closed or an open lattice structure and is typically fabricated from a malleable or elastic material.
- a malleable material such as stainless steel, gold, platinum, titanium, cobalt chromium and other alloys
- the stent segments are typically expanded by balloon inflation, causing plastic deformation of the lattice so that it remains permanently deformed in the open position after deployment.
- the lattice structures When formed from an elastic material, including superelastic materials such as nickel-titanium alloys, the lattice structures are commonly constrained radially during delivery and upon deployment the constraining structure is removed, allowing the prosthesis to "self-expand" at the target site.
- the terms “stent, " “prosthetic segment” and “stent segments” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within a body lumen.
- an apparatus for delivering prosthetic segments in a body lumen comprises an elongated flexible member with proximal and distal ends and a plurality of prosthetic segments releasably arranged axially along the elongated flexible member near the distal end.
- the apparatus also has a sheath that is slidably disposed over at least a portion of the prosthetic segments and an outer shaft that is slidably disposed over at least a portion of the sheath.
- a separator is disposed on the outer shaft and is biased into engagement with at least one prosthetic segment so that the outer shaft may be retracted to separate a proximal group of prosthetic segments from a distal group of prosthetic segments which are to be deployed in the body lumen.
- the sheath is also positionable between the separator and the prosthetic segments to selectively disengage the separator from the prosthetic segments.
- the separator is adapted to apply substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally.
- the sheath is configured to engage the outer shaft such that retraction of the sheath retracts the outer shaft.
- Both the sheath and outer shaft typically comprise an annular flange that allows the two members to engage one another.
- the apparatus also usually includes an expandable member near the distal end of the elongate flexible member and typically the expandable member is a balloon.
- the prosthetic segments are balloon expandable, although they may also be self-expanding. Additionally, the prosthetic segments may carry a therapeutic agent such as an anti -restenosis drug which may be released from the segments.
- the segments are often in the range of size from about 2 mm to about 10 mm, although they typically have a length about 3 mm to about 6 mm. In some embodiments, the prosthetic segments may have two or more lengths, while in other embodiments, the segments are substantially the same length.
- the prosthetic segments have interleaved ends in engagement with each other prior to deployment although the segments may also be spaced apart prior to deployment. Spacing the segments apart allows the separator to engage the prosthetic segments at their distal ends.
- the separator often comprises a plurality of resilient fingers projecting radially inward. At least some of these fingers may be inclined so that the free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but to engage a prosthetic segment when the separator is retracted proximally.
- some of the fingers are composed of metal, while they may also be composed of a polymer.
- Some of the fingers may comprise a radiused end that substantially matches the curvature of the surface of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segments and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
- the separator further comprises a hinge coupled to the fingers to allow the fingers to deflect radially and this facilitates passage of the separator over the sheath when the separator is advanced distally.
- the separator comprises an annular flange and this flange may be tapered or it can be a tapered conical nose.
- Other embodiments of the separator comprise a plurality of inclined ramps disposed on an inner surface of the outer shaft and these ramps may be separated by about ninety degrees.
- the separator may comprise a compliant sharp edge.
- a method for delivering prosthetic segments to a body lumen comprises introducing a plurality of prosthetic segments that are releasably arranged axially along an elongated flexible member, into a body lumen having a lesion with a lesion length at a first treatment site.
- An outer shaft having a separator is distally advanced relative to a group of prosthetic segments selected for delivery and the selected group typically has a combined length that matches the lesion length.
- a sheath, disposed between the separator and the prosthetic segments is then positioned until the separator is allowed to engage the prosthetic segments.
- the outer shaft is then retracted thereby creating a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongated flexible member.
- the selected group of prosthetic segments is then deployed at the first treatment site.
- a method for selectively delivering prosthetic segments to a lesion in a treatment region in a body lumen comprises advancing a delivery catheter through the body lumen, which may be a blood vessel, to the treatment region.
- a plurality of prosthetic segments is often disposed axially along the delivery catheter.
- An outer shaft having a separator is distally advanced.
- a sheath disposed between the separator and the prosthetic segments is positioned until the separator is allowed to engage the prosthetic segments.
- the outer shaft can then be retracted proximally so as to create a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongate flexible member.
- Inflating a balloon disposed on the delivery catheter deploys the group of prosthetic segments while any remaining prosthetic segments stay with the delivery catheter.
- the sheath is configured to engage the outer shaft such that retraction of the sheath also retracts the outer shaft.
- the prosthetic segments are typically balloon expandable, but they may also be self-expanding, and they are usually introduced into a blood vessel.
- deploying the selected group of prosthetic segments comprises plastically deforming the selected group of prosthetic segments, and often this is accomplished with a balloon.
- the plurality of prosthetic segments carries a therapeutic agent that is adapted to being released from the segments, and typically this agent is an anti- restenosis drug.
- the prosthetic segments have a length in the range from about 2 mm to about 10 mm, while in others, the segments have a length about 3 mm to about 6 mm.
- the segments may also be spaced apart prior to deployment to allow the separator to engage the prosthetic segments at their distal ends.
- the separator exerts substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally.
- the separator comprises a plurality of resilient fingers projecting radially inward. Often, at least some of the fingers are inclined so that free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but to engage a prosthetic segment when the separator is retracted proximally.
- Some of the fingers may be composed of metal, while in other embodiments, some of the fingers may be composed of a polymer.
- the fingers comprise a radiused end that substantially matches the curvature of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segment and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
- Some embodiments may include a separator that comprises a hinge coupled to the fingers. The hinge helps the fingers to deflect radially outward over the sheath when the separator is advanced distally.
- the separator comprises an annular flange and the flange may be tapered or may have a tapered conical nose.
- the separator comprises a plurality of inclined ramps that are disposed on an inner surface of the outer shaft. Often these ramps are separated by about ninety degrees. In yet other embodiments, the separator may comprise a sharp compliant edge.
- FIG. 1 is a perspective view of a stent delivery system in accordance with one embodiment of the present invention.
- Figs. 2A-2F show selection and deployment of prosthetic stent segments in accordance with an exemplary embodiment.
- a stent delivery catheter 100 comprises a catheter shaft 120 with an outer shaft 124 slidably disposed over a sheath 144 which is in turn slidably disposed over an inner shaft 216 (seen in Fig. 2A).
- An inflatable balloon 130 is mounted on the inner shaft 216 and is exposed by retracting outer shaft 124 and sheath 144 relative to the inner shaft 216.
- a tapered nosecone 136 composed of a soft elastomeric material to minimize trauma to the vessel during advancement of the delivery catheter 100, is attached distally of the inflatable balloon 130.
- Prosthesis 126 comprises a plurality of prosthetic segments 128 mounted over the inflatable balloon 130 for expansion.
- Sheath 144 covers the prosthetic segments 128 and protects them from being damaged during delivery.
- a guidewire tube 122 is slidably positioned through shaft 124 and sheath 144 proximal to the inflatable balloon 130.
- a guidewire 138 is positioned slidably through guidewire tube 122, inflatable balloon 130 and nosecone 136, and extends distally thereof.
- Fig. 1 illustrates the stent delivery catheter 100 and Fig. 2A shows various elements of the delivery catheter 100 in greater detail.
- a stent delivery catheter 200 is slidably disposed over the guidewire GW into the vessel V so that the nosecone 210 is distal to the lesion L.
- the delivery catheter 200 has an expandable member 204 disposed over an inner catheter shaft 216 and stent segments 202 having interleaved ends in engagement with each other are disposed over the expandable member 204, which is a balloon in this embodiment.
- the stent segments 202 are covered by sheath 208.
- the sheath 208 protects stent segments 202 during delivery and also prevents unintended axial displacement of the segments 202.
- six stent segments 202 are disposed on the stent delivery catheter 200.
- the prosthetic segments 202 are disposed over a balloon 204 near the distal end of the stent delivery catheter 200.
- a stent valve 206 is disposed on the inner surface of outer shaft 21 1 and is adapted to engage prosthetic segments 202 and facilitates their deployment.
- sheath 208 has an annular flange or tab 212 disposed on its outer surface that is adapted to pass through the stent valve 206 during retraction or advancement and to engage the annular flange or tab 214 disposed on the inner surface of outer shaft 21 1
- a handle 106 is attached to a proximal end 1 12 of the outer shaft 124.
- the handle performs several functions, including retracting and advancing the outer shaft 124 and sheath 144 thereby exposing prosthetic segments 128 and allowing the prosthetic segments 128 to be delivered. Additionally, using the handle 106 to displace the sheath 144 permits creation of a spacing between prosthetic segments 128 selected for delivery and the segments 128 that will remain with the delivery catheter 100. This gap or spacing between segments permits proper balloon inflation and will be described below in further detail along with the handle structure and operation.
- Handle 106 includes a housing 1 10 which encloses the internal components of the handle 106. Handle 106 allows a physician operator to advance or retract outer shaft 124 and sheath 144, which determines the length of the prosthesis (number of segments) to be deployed. The handle 106 also permits connection of balloon 130 to an inflation source.
- the inner shaft 216 is preferably fixed to the handle housing 1 10, while both outer shaft 124 and sheath 144 are coupled to slide mechanisms 102 and 140, respectively. Slide mechanisms 102 and 140 allow both the outer shaft 124 and sheath 144 to be independently retracted and advanced relative to handle 106.
- An adaptor 108 is attached to handle 106 at its proximal end and is fluidly coupled to the inner shaft 216 in the interior of the housing of handle 106.
- the adaptor 108 preferably a Luer connector, is configured to be fluidly coupled with an inflation device which may be any commercially available balloon inflation device such as those sold under the trade name "IndeflatorTM,” manufactured by Abbott (formerly Guidant Corporation of Santa Clara, CA)
- the adaptor is in fluid communication with the inflatable balloon 130 via an inflation lumen in the inner shaft 216 to permit inflation of the inflatable balloon 130
- a control mechanism on the handle 106 includes a slide mechanism 102 that translates along calibrated slot 104
- Slide mechanism 102 is coupled with outer shaft 124 and is adapted to retract or advance the shaft 124 a selected distance Initially, the distance is selected by advancing slide mechanism 102 distally along slot 104
- the slide mechanism 102 includes visual markers 148 so that an operator can easily determine how many stent segments have been selected
- slide mechanism 102 may have detents or a ratchet that piovides audible or tactile feedback to the operator to facilitate operation of the stent delivery catheter 100 without requiring direct visualization during operation
- Handle 106 also comprises a second control mechanism 140 that translates along calibrated slot 142 Slide mechanism 140 is coupled with the sheath 144 and is adapted to retract or advance the sheath 144 a selected distance After the number of prosthetic segments 128 has been selected as described above, slide mechanism 140 is retracted so as to cause proximal retraction of sheath 144 As sheath 144 is retracted, tabs 212 (Fig 2A) engage with tabs 214 (Fig 2A) on outer shaft 124 Further retraction of sheath 144 also retracts outer shaft 124 and exposes the prosthetic segments 128 selected for delivery and creates a spacing between the segments selected for delivery and the segments remaining with the delivery catheter 100 Slide mechanism 140 also includes visual markers 150 that help the physician with operation of the control mechanism 140 Additionally, the slide mechanism 140 may comprise detents or a ratchet that further assists physician operation by providing audible or tactile feedback This se ⁇ es of steps is illustrated in Figs 2A-2F and is described in more detail below
- the slider assembly 132 is adapted for insertion into and sealing with a hemostasis valve, such as on an introducer sheath or guiding catheter, while still allowing relative movement of the outer shaft 124 and sheath 144 relative to the slider assembly 132.
- the slider assembly 132 includes a slider tube 1 18, a slider body 1 16, and a slider cap 1 14.
- Outer shaft 124 and sheath 144 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of inflatable balloon 130, and/or the like.
- Inflatable balloon 130 may be formed of a semi-compliant polymer such as Pebax, Nylon, polyurethane, polypropylene, PTFE or other suitable polymers. Additional aspects of the luminal prosthesis delivery system are described in U.S. Patent Application Serial No. 10/306,813, filed November 27, 2002 (Attorney Docket No. 021629-000320US); U.S.
- Patent Application Serial No. 10/637,713, filed August 8, 2003 (Attorney Docket No. 021629-000340US); U.S. Patent Application Serial No. 10/738,666, filed December 16, 2003 (Attorney Docket No. 021629-00051 OUS); U.S. Patent Application Serial No. 1 1/104,305, filed April 1 1 , 2005 (Attorney Docket No. 021629-003300US); and U.S. Application Serial No. 1 1/148,585, filed June 8, 2005, the full disclosures of which are hereby incorporated by reference.
- Delivery catheter 100 also includes a separator or "stent valve " ' disposed near the distal end of outer shaft 21 1 and an exemplary embodiment of this is seen in Fig. 2A.
- outer shaft 21 1 is retracted so that its distal tip is proximal to the proximal-most end of the prosthetic stent segments 202.
- sheath 208 is advanced fully distally, covering the plurality of prosthetic segments 202 which are disposed over expandable member 204.
- Expandable member 204 acts as a carrier which supports the prosthetic segments 202.
- Separator 206 contacts and engages prosthetic segments 202.
- separator 206 includes proximally inclined resilient fingers configured to frictionally engage stent segments 202 when sheath 208 has been retracted and prosthetic segments 202 are exposed.
- the separator 206 may be a polymeric or metallic material integrally formed with outer shaft 21 1 , or it may be bonded or otherwise mounted to the interior of the outer shaft 21 1.
- the geometry of separator 206 can also be toroidal with a circular or ovoid cross-section (like an O-ring) or the separator 206 may have another cross-sectional shape such as triangular, trapezoidal, pyramidal, or other shapes as described in embodiments discussed more fully herein below.
- the separator 206 can be a polymer such as silicone or urethane, sufficiently soft, compliant and resilient to provide frictional engagement with stent segments 202, in some embodiments without damaging any coating deposited thereon, including therapeutic drug coatings.
- the separator 206 extends radially inwardly a sufficient distance to engage the exterior of stent segments 202 with sufficient force to allow the stent segments not selected for delivery to be retracted proximally with outer shaft 21 1 so as to create a spacing relative to those stent segments selected for delivery.
- Other exemplary embodiments of separators along with additional aspects of separator 206 are described in U.S. Patent Application Serial No. 10/412,714, filed April 10, 2003 (Attorney Docket No. 021629-000330US); U.S. Patent Application Serial No. 1 1/344,464, filed January 30, 2006 (Attorney Docket No. 021629-003500US); and U.S. Patent Application Serial No. 1 1/469,773, filed September 1 , 2006 (Attorney Docket No. 021629- 004000US), the entire contents of which are incorporated herein by reference.
- Prosthesis 126 is composed of one or more prosthetic segments 128.
- Prosthetic stent segments 128 are disposed over an inflation balloon 130.
- Each stent segment is about 2-20 mm in length, more typically about 2-10 mm in length and preferably being about 2-8 mm in length.
- Usually 2-20, more typically 2-10 and preferably 2-6 stent segments 128 may be positioned axially over the inflation balloon 130 and the inflation balloon 130 has a length suitable to accommodate the number of stent segments.
- Stent segments 128 may be positioned in direct contact with an adjacent stent segment so that segment ends are interleaved or there may be a spacing between segment ends. When the segments are spaced apart from one another, the spacing is typically between 0.5 mm and 1 mm.
- the stent segments 128 may be deployed individually or in groups of two or more at a single treatment site within the vessel lumen.
- Prosthetic stent segments 128 are preferably composed of a malleable metal so they may be plastically deformed by inflation balloon 130 as they are radially expanded to a desired diameter in the vessel at the target treatment site.
- the stent segments 128 may also be composed of an elastic or superelastic shape memory alloy such as Nitinol so that the stent segments 128 self-expand upon release into a vessel by retraction of the sheath 124.
- an inflation balloon 130 is not required but may still be used for predilation of a lesion or augmenting expansion of the self-expanding stent segments (e.g. postdilation or tacking).
- Other materials such as biocompatible polymers may be used to fabricate prosthetic stent segments and these materials may further include bioabsorbable or bioerodable properties.
- Stent segments 128 may have any of a variety of common constructions, such as but not limited to those described in U.S. Patent Application Serial No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 02169-00051 OUS), which was previously incorporated by reference. Constructions may include for example, closed cell constructions including expansible ovals, ellipses, box structures, expandable diamond structures, etc. In addition, the closed cells may have complex slotted geometries such as H-shaped slots, I-shaped slots, J- shaped slots, etc. Suitable open cell structures include zigzag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature.
- prosthetic stent segments 128 may be coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Paclitaxel, analogs, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable polymeric carrier.
- stent segments 128 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics and/or stem cells.
- Such materials may be coated over all or a portion of the surface of stent segments 128, or stent segments 128 may have a porous structure or include apertures, holes, channels, or other features in which such materials may be deposited.
- FIGs. 2A-2F the deployment of selected prosthetic segments to treat a stenotic lesion is shown in accordance with an exemplary embodiment. While the embodiment will be described in the context of a coronary artery stent procedure, it should be understood that the invention may be employed in any variety of blood vessels and other body lumens in which stents or tubular prostheses are deployed, including the carotid, femoral, iliac and other arteries and vein, as well as non-vascular body lumens, such as the ureter, urethra, fallopian tubes, the hepatic duct and the like.
- a guide catheter (not illustrated) is first inserted into a peripheral artery such as the femoral artery, typically using a percutaneous procedure such as the Seldinger technique or by surgical cutdown, and then advanced to the ostium of the right or left coronary artery.
- Guidewire GW is then inserted through the guiding catheter and advanced to the target vessel V, where the lesion L to be treated is located.
- the proximal end of guidewire GW is then inserted through nose cone 210, through the catheter shaft 216 and exits guidewire tube 122 (seen in Fig. 1 ) which is outside the patient ' s body.
- Fig. 2A shows stent delivery catheter 200 slidably advanced over the guidewire GW into the vessel V so that the nosecone 210 is distal to the lesion L.
- the delivery catheter 200 has an expandable member 204 disposed over a catheter shaft 216 and stent segments 202 having interleaved ends in engagement with each other are disposed over the expandable member 204, which is a balloon in this embodiment.
- the stent segments 202 are covered by sheath 208.
- the sheath 208 protects stent segments 202 during delivery and also prevents unintended axial displacement of the segments 202.
- six stent segments 202 are disposed on the stent delivery catheter 200, each having a length approximately 6 mm long.
- the delivery catheter 200 is adapted to deliver a prosthesis having a length ranging from 6 mm long, up to 36 mm long in 6 mm increments.
- Other lengths and quantities of stent segments may be employed and this exemplary embodiment is not meant to limit the scope of the present invention.
- a separator or stent valve 206 is disposed on the inner surface of outer shaft 21 1 and is adapted to engage prosthetic segments 202 and facilitates their deployment.
- sheath 208 has an annular flange or tab 212 disposed on its outer surface that is adapted to pass through the stent valve 206 during retraction or advancement and to engage the annular flange or tab 214 disposed on the inner surface of outer shaft 21 1.
- the length of the lesion to be treated is typically visualized by introducing contrast media into the target vessel V and observing the resulting image under a fluoroscope.
- Radiopaque markers 226, 228, one at the distal end of the balloon 204 and one at the distal end of the outer shaft 21 1 may be used to visualize the length of stent segments 202 exposed for deployment relative to the target lesion. This is accomplished by advancing the delivery catheter 200 so that radiopaque marker 226 is at the distal edge of the lesion and then outer shaft 21 1 is advanced until radiopaque marker 228 is at the proximal edge of the lesion.
- stent segments 218 being selected to match the length of lesion L, as shown in Fig. 2B.
- outer shaft 21 1 is advanced distally so as to select two prosthetic segments 218 having a combined length of approximately 12 mm. Additional prosthetic segments 202 may be selected if necessary, although here, four prosthetic segments 202 will remain with the delivery catheter 200.
- stent valve 206 is angled inwardly and adapted so that it will slide over sheath 208 without hindering distal motion of outer shaft 21 1. Advancement of outer shaft 21 1 may be controlled by the control mechanism 106 illustrated in Fig. 1 , although other actuators may be employed.
- the selected segments 218 are exposed in preparation for delivery.
- sheath 208 is retracted proximally and thus the selected prosthetic segments 218 are no longer constrained from expansion.
- sheath 208 is retracted, its annular flange 212 slides past the stent valve 206. Retraction of sheath 208 continues until the sheath annular flange 212 engages the outer shaft annular flange 214.
- the two flanges 212, 214 are designed to provide a positive stop to one another.
- continued retraction of sheath 208 results in simultaneous retraction of outer shaft 21 1 , as shown in Fig. 2D.
- Retraction of sheath 208 can be accomplished using the control mechanism 140 depicted in Fig. 1.
- stent valve 206 is no longer disposed over sheath 208.
- the stent valve 206 now engages the distal-most prosthetic segment 202 in the group of prosthetic segments remaining with the delivery catheter 200, and this is shown in Fig 2D.
- Stent valve 206 is inclined such that further retraction of sheath 208 not only retracts outer shaft 21 1 , but stent valve 206 also retracts the group of prosthetic segments 202 that remain with the delivery catheter 200, thereby creating a spacing between prosthetic segments 202 remaining with the delivery catheter 200 and the prosthetic segments 218 to be delivered.
- This spacing is typically between 0.5 mm and 5 mm and is required in order to allow a balloon taper to form during balloon inflation.
- other stent valves are contemplated, including those disclosed in co-pending application number 1 1/469,773, filed September 1 , 2006 (Attorney Docket No. 021629-004000US), entitled “Custom Length Stent Apparatus,” the contents of which have previously been incorporated herein by reference.
- Expandable member 204 here, a balloon
- a fluid such as contrast media and/or saline
- Radial expansion of the balloon 204 to an enlarged diameter 222 correspondingly expands stent segments 218 to an expanded diameter 220 outward against the vessel wall across lesion L.
- the proximal portion of expandable member 204 is constrained by sheath 208 and radiopaque marker 228, preventing its expansion and deployment of the remaining prosthetic segments 202.
- stent segments 220 are deployed, expanded balloon 222 is deflated and removed from the deployed stent segments 220, leaving them in a plastically deformed, expanded configuration in the vessel V, at the site of the lesion, L. This is shown in Fig. 2F. Stent segments 202 remain with the delivery catheter 200 which is then removed and retracted from the vessel V.
Abstract
Apparatus and methods for delivering prosthetic segments to a body lumen include an elongated flexible member having both proximal and distal ends along with a plurality of prosthetic segments releasably arranged axially along the elongated flexible member near the distal end. Additionally, the apparatus has a sheath slidably disposed over at least a portion of the prosthetic segments and an outer shaft slidably disposed over at least a portion of the sheath. A separator is disposed on the outer shaft and is biased into engagement with at least one prosthetic segment so that the outer shaft may be retracted to separate a proximal group of prosthetic segments from a distal group of prosthetic segments which are to be deployed into the body lumen. The sheath is positionable between the separator and the prosthetic segments to selectively disengage the separator from the prosthetic segments.
Description
CUSTOM LENGTH STENT APPARATUS
BACKGROUND OF THE INVENTION
(0001 ] 1 . Field of the Invention. This invention relates generally to medical apparatus and methods, and more specifically to vascular catheters, stents and stent delivery systems for use in the coronary arteries and other vessels.
[0002] Stenting is an important treatment option for patients with vascular occlusive disease. The stenting procedure involves placing a tubular prosthesis at the site of a lesion, typically within a diseased coronary artery. The procedure is performed in order to maintain the patency of the artery and is often performed after a primary treatment such as angioplasty. Early stent results suffered from high rates of restenosis, i.e. the tendency for the stented coronary artery to become re-occluded following implantation of the stent. However, in recent years, restenosis rates have decreased substantially, due in part to drug eluting stents as well as other improvements in stent delivery methods and stent technology. As a result, the number of stent related procedures being performed worldwide continues to dramatically increase.
|0003] Stents are typically either self-expanding or balloon expandable and they are delivered to the coronary arteries using long, flexible vascular catheters typically inserted percutaneously through the patient's femoral artery. For self-expanding stents, the stent is simply released from the delivery catheter and it resiliency expands into engagement with the vessel wall. For balloon expandable stents, a balloon on the delivery catheter is expanded which expands and deforms the stent to the desired diameter, whereupon the balloon is deflated and removed, leaving the stent in place.
[0004] Current stent delivery technology suffers from a number of drawbacks which can make delivery of stents challenging. In particular, current stent delivery catheters often employ stents having fixed lengths. The proper selection of fixed length stents requires accurate knowledge of the lesion length being treated. While lesion length may be measured prior to stent deployment using angiography and fluoroscopy, these measurements are often inaccurate. Thus, if an improperly sized stent is introduced to a treatment site, the delivery catheter and stent must be removed from the patient and replaced with a different device
having the correct size. This prolongs the procedure, increases waste and results in a more costly procedure.
[0005] The use of "custom length" stents as an alternative to fixed length stents has been proposed. One such approach for providing a custom length stent has been to use segmented stents for treatment in which only some of the stents are deployed for treatment. Several exemplary systems are described in several copending, commonly assigned applications which are listed below. In these systems, the stent segments are deployed by selective advancement over the delivery catheter. After delivering an initial group of segments, the catheter may be repositioned to a new treatment site and a further group of segments can then be deployed. These systems can enable treatment of multiple lesions with a single device and may contain up to fifty segments. While this technology represents a significant improvement over earlier stent delivery systems, in the case of smaller, more focal lesions or single lesions, only a small number of stent segments are needed and thus there is considerable waste when a large number of stent segments remain undeployed and end up being discarded at the end of the procedure.
[0006] Another challenge with existing "custom length" stent delivery systems is that to deliver multiple stent segments to multiple lesion sites requires an intricate delivery system that can be somewhat complex to use. Thus, a simpler delivery system that allows length customization with fewer prosthetic segments on the delivery catheter is desirable, especially for use in treating a single lesion. It is also desirable to protect stent segments on the delivery system from being improperly displaced, deformed or damaged during delivery and deployment.
[0007] For the above reasons as well as others, it would be desirable to provide improved prosthetic stents and delivery catheters. It would be particularly desirable to provide catheters which enable stent length to be customized yet have a minimal quantity of stent segments so as to treat common lesion lengths while minimizing stent segment waste. It is also desirable to provide a delivery system that is flexible and can track torturous vessels and that has a simple construction and is less costly and easy to use in deploying a selectable number of stent segments to a single treatment site.
[0008] 2. Description of the Background Art. Prior publications describing catheters for delivering multiple segmented stents include: U.S. Publication Nos. 2004/0098081 , 2005/0149159, 2004/0093061 , 2005/0010276, 2005/0038505, 2004/0186551 and
2003/013266. Prior related unpublished co-pending U.S. patent applications include serial number 1 1/148,713, filed June 8, 2005 (Attorney Docket No. 14592.4002), entitled "Devices and Methods for Operating and Controlling Interventional Apparatus"; serial number 1 1/148,545, filed June 8, 2005 (Attorney Docket No. 14592.4005), entitled "Apparatus and Methods for Deployment of Multiple Custom-Length Prosthesis"; serial number 1 1/344,464, filed January 30, 2006 (Attorney Docket No. 021629-003500US). entitled "Apparatus and Methods for Deployment of Custom-Length Prostheses"; and serial number 60/784,309, filed March 20, 2006 (Attorney Docket No. 021629-003600US), entitled "Apparatus and Methods for Deployment of Linked Prosthetic Segments." The full disclosures of each of these patents and applications are incorporated herein by reference.
BRIEF SUMMARY OF THE INVENTION
[0009] The invention generally provides for the delivery of prosthetic segments with a flexible delivery catheter capable of navigating torturous vessels such as the coronary arteries. The delivery catheter permits deployment of a selectable number of prosthetic segments at a single treatment site, thus allowing customization of prosthesis length while the delivery catheter is in a body lumen at a treatment site. Customization of prosthesis length in situ permits better matching of the prosthesis length to the lesion length being treated. The delivery catheter has a simplified design including a control mechanism on the catheter handle for selecting prosthetic segments for deployment and a stent valve or separator on the distal end of an outer shaft that facilitates deployment of the selected group of stent segments. A sheath protects the prosthetic segments from damage during delivery and deployment.
[0010] The terms "stent'" and "stenting" are defined to include any of the array of expandable prostheses and scaffolds which are introduced into a lumen at a target treatment site and expanded in situ thereby exerting a radially outward force against the lumen wall. The prosthesis of the present invention comprises a closed or an open lattice structure and is typically fabricated from a malleable or elastic material. When a malleable material is used, such as stainless steel, gold, platinum, titanium, cobalt chromium and other alloys, the stent segments are typically expanded by balloon inflation, causing plastic deformation of the lattice so that it remains permanently deformed in the open position after deployment. When formed from an elastic material, including superelastic materials such as nickel-titanium alloys, the lattice structures are commonly constrained radially during delivery and upon deployment the constraining structure is removed, allowing the prosthesis to "self-expand" at
the target site. The terms "stent," "prosthetic segment" and "stent segments" refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within a body lumen.
[001 Ij In a first aspect of the invention, an apparatus for delivering prosthetic segments in a body lumen comprises an elongated flexible member with proximal and distal ends and a plurality of prosthetic segments releasably arranged axially along the elongated flexible member near the distal end. The apparatus also has a sheath that is slidably disposed over at least a portion of the prosthetic segments and an outer shaft that is slidably disposed over at least a portion of the sheath. A separator is disposed on the outer shaft and is biased into engagement with at least one prosthetic segment so that the outer shaft may be retracted to separate a proximal group of prosthetic segments from a distal group of prosthetic segments which are to be deployed in the body lumen. The sheath is also positionable between the separator and the prosthetic segments to selectively disengage the separator from the prosthetic segments.
[0012] In preferred embodiments, the separator is adapted to apply substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally. Often, the sheath is configured to engage the outer shaft such that retraction of the sheath retracts the outer shaft. Both the sheath and outer shaft typically comprise an annular flange that allows the two members to engage one another. The apparatus also usually includes an expandable member near the distal end of the elongate flexible member and typically the expandable member is a balloon.
[0013] Often, the prosthetic segments are balloon expandable, although they may also be self-expanding. Additionally, the prosthetic segments may carry a therapeutic agent such as an anti -restenosis drug which may be released from the segments. The segments are often in the range of size from about 2 mm to about 10 mm, although they typically have a length about 3 mm to about 6 mm. In some embodiments, the prosthetic segments may have two or more lengths, while in other embodiments, the segments are substantially the same length. Often, the prosthetic segments have interleaved ends in engagement with each other prior to deployment although the segments may also be spaced apart prior to deployment. Spacing the segments apart allows the separator to engage the prosthetic segments at their distal ends.
[0014] The separator often comprises a plurality of resilient fingers projecting radially inward. At least some of these fingers may be inclined so that the free ends of the fingers
point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but to engage a prosthetic segment when the separator is retracted proximally. In some embodiments, some of the fingers are composed of metal, while they may also be composed of a polymer. Some of the fingers may comprise a radiused end that substantially matches the curvature of the surface of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segments and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
[0015] In other embodiments, the separator further comprises a hinge coupled to the fingers to allow the fingers to deflect radially and this facilitates passage of the separator over the sheath when the separator is advanced distally. Often the separator comprises an annular flange and this flange may be tapered or it can be a tapered conical nose. Other embodiments of the separator comprise a plurality of inclined ramps disposed on an inner surface of the outer shaft and these ramps may be separated by about ninety degrees. In still other embodiments, the separator may comprise a compliant sharp edge.
[0016] In another aspect of the present invention, a method for delivering prosthetic segments to a body lumen comprises introducing a plurality of prosthetic segments that are releasably arranged axially along an elongated flexible member, into a body lumen having a lesion with a lesion length at a first treatment site. An outer shaft having a separator is distally advanced relative to a group of prosthetic segments selected for delivery and the selected group typically has a combined length that matches the lesion length. A sheath, disposed between the separator and the prosthetic segments is then positioned until the separator is allowed to engage the prosthetic segments. The outer shaft is then retracted thereby creating a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongated flexible member. The selected group of prosthetic segments is then deployed at the first treatment site.
[0017] In still another aspect of the present invention, a method for selectively delivering prosthetic segments to a lesion in a treatment region in a body lumen comprises advancing a delivery catheter through the body lumen, which may be a blood vessel, to the treatment region. A plurality of prosthetic segments is often disposed axially along the delivery catheter. An outer shaft having a separator is distally advanced. A sheath disposed between the separator and the prosthetic segments is positioned until the separator is allowed to
engage the prosthetic segments. The outer shaft can then be retracted proximally so as to create a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongate flexible member. Inflating a balloon disposed on the delivery catheter deploys the group of prosthetic segments while any remaining prosthetic segments stay with the delivery catheter.
[0018) Often, the sheath is configured to engage the outer shaft such that retraction of the sheath also retracts the outer shaft. Additionally, the prosthetic segments are typically balloon expandable, but they may also be self-expanding, and they are usually introduced into a blood vessel. Often, deploying the selected group of prosthetic segments comprises plastically deforming the selected group of prosthetic segments, and often this is accomplished with a balloon. Often, the plurality of prosthetic segments carries a therapeutic agent that is adapted to being released from the segments, and typically this agent is an anti- restenosis drug.
[0019] In some embodiments, the prosthetic segments have a length in the range from about 2 mm to about 10 mm, while in others, the segments have a length about 3 mm to about 6 mm. Often prosthetic segments have interleaved ends in engagement with each other prior to deployment, although the segments may also be spaced apart prior to deployment to allow the separator to engage the prosthetic segments at their distal ends.
[0020] Typically, the separator exerts substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally. In some embodiments, the separator comprises a plurality of resilient fingers projecting radially inward. Often, at least some of the fingers are inclined so that free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but to engage a prosthetic segment when the separator is retracted proximally. Some of the fingers may be composed of metal, while in other embodiments, some of the fingers may be composed of a polymer.
[0021] In other embodiments, at least some of the fingers comprise a radiused end that substantially matches the curvature of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segment and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator. Some embodiments may include a separator that comprises a hinge coupled to the fingers. The hinge helps the fingers
to deflect radially outward over the sheath when the separator is advanced distally. Often, the separator comprises an annular flange and the flange may be tapered or may have a tapered conical nose.
[0022] In still other embodiments, the separator comprises a plurality of inclined ramps that are disposed on an inner surface of the outer shaft. Often these ramps are separated by about ninety degrees. In yet other embodiments, the separator may comprise a sharp compliant edge.
[0023] These an other embodiments are described in further details in the following description related to the appended drawing figures.
BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Fig. 1 is a perspective view of a stent delivery system in accordance with one embodiment of the present invention.
[0025] Figs. 2A-2F show selection and deployment of prosthetic stent segments in accordance with an exemplary embodiment.
DETAILED DESCRIPTION OF THE INVENTION
[0026] Referring now to Fig. 1 , a stent delivery catheter 100 comprises a catheter shaft 120 with an outer shaft 124 slidably disposed over a sheath 144 which is in turn slidably disposed over an inner shaft 216 (seen in Fig. 2A). An inflatable balloon 130, is mounted on the inner shaft 216 and is exposed by retracting outer shaft 124 and sheath 144 relative to the inner shaft 216. A tapered nosecone 136, composed of a soft elastomeric material to minimize trauma to the vessel during advancement of the delivery catheter 100, is attached distally of the inflatable balloon 130. Prosthesis 126 comprises a plurality of prosthetic segments 128 mounted over the inflatable balloon 130 for expansion. Sheath 144 covers the prosthetic segments 128 and protects them from being damaged during delivery. A guidewire tube 122 is slidably positioned through shaft 124 and sheath 144 proximal to the inflatable balloon 130. A guidewire 138 is positioned slidably through guidewire tube 122, inflatable balloon 130 and nosecone 136, and extends distally thereof. Fig. 1 illustrates the stent delivery catheter 100 and Fig. 2A shows various elements of the delivery catheter 100 in greater detail.
[0027] In Fig. 2A, a stent delivery catheter 200 is slidably disposed over the guidewire GW into the vessel V so that the nosecone 210 is distal to the lesion L. The delivery catheter 200
has an expandable member 204 disposed over an inner catheter shaft 216 and stent segments 202 having interleaved ends in engagement with each other are disposed over the expandable member 204, which is a balloon in this embodiment. The stent segments 202 are covered by sheath 208. The sheath 208 protects stent segments 202 during delivery and also prevents unintended axial displacement of the segments 202. In this embodiment, six stent segments 202 are disposed on the stent delivery catheter 200. The prosthetic segments 202 are disposed over a balloon 204 near the distal end of the stent delivery catheter 200. A stent valve 206 is disposed on the inner surface of outer shaft 21 1 and is adapted to engage prosthetic segments 202 and facilitates their deployment. Additionally, sheath 208 has an annular flange or tab 212 disposed on its outer surface that is adapted to pass through the stent valve 206 during retraction or advancement and to engage the annular flange or tab 214 disposed on the inner surface of outer shaft 21 1
|0028] In Fig. 1 , a handle 106 is attached to a proximal end 1 12 of the outer shaft 124. The handle performs several functions, including retracting and advancing the outer shaft 124 and sheath 144 thereby exposing prosthetic segments 128 and allowing the prosthetic segments 128 to be delivered. Additionally, using the handle 106 to displace the sheath 144 permits creation of a spacing between prosthetic segments 128 selected for delivery and the segments 128 that will remain with the delivery catheter 100. This gap or spacing between segments permits proper balloon inflation and will be described below in further detail along with the handle structure and operation.
[0029] Handle 106 includes a housing 1 10 which encloses the internal components of the handle 106. Handle 106 allows a physician operator to advance or retract outer shaft 124 and sheath 144, which determines the length of the prosthesis (number of segments) to be deployed. The handle 106 also permits connection of balloon 130 to an inflation source. The inner shaft 216 is preferably fixed to the handle housing 1 10, while both outer shaft 124 and sheath 144 are coupled to slide mechanisms 102 and 140, respectively. Slide mechanisms 102 and 140 allow both the outer shaft 124 and sheath 144 to be independently retracted and advanced relative to handle 106. An adaptor 108 is attached to handle 106 at its proximal end and is fluidly coupled to the inner shaft 216 in the interior of the housing of handle 106. The adaptor 108, preferably a Luer connector, is configured to be fluidly coupled with an inflation device which may be any commercially available balloon inflation device such as those sold under the trade name "Indeflator™," manufactured by Abbott (formerly Guidant Corporation
of Santa Clara, CA) The adaptor is in fluid communication with the inflatable balloon 130 via an inflation lumen in the inner shaft 216 to permit inflation of the inflatable balloon 130
[003Oj Additionally, a control mechanism on the handle 106 includes a slide mechanism 102 that translates along calibrated slot 104 Slide mechanism 102 is coupled with outer shaft 124 and is adapted to retract or advance the shaft 124 a selected distance Initially, the distance is selected by advancing slide mechanism 102 distally along slot 104 This allows the physician opeiator to select the number of prosthetic segments 128 on the distal end of dehveiy catheter 100 that will be delivered The slide mechanism 102 includes visual markers 148 so that an operator can easily determine how many stent segments have been selected In preferred embodiments, slide mechanism 102 may have detents or a ratchet that piovides audible or tactile feedback to the operator to facilitate operation of the stent delivery catheter 100 without requiring direct visualization during operation
[0031] Handle 106 also comprises a second control mechanism 140 that translates along calibrated slot 142 Slide mechanism 140 is coupled with the sheath 144 and is adapted to retract or advance the sheath 144 a selected distance After the number of prosthetic segments 128 has been selected as described above, slide mechanism 140 is retracted so as to cause proximal retraction of sheath 144 As sheath 144 is retracted, tabs 212 (Fig 2A) engage with tabs 214 (Fig 2A) on outer shaft 124 Further retraction of sheath 144 also retracts outer shaft 124 and exposes the prosthetic segments 128 selected for delivery and creates a spacing between the segments selected for delivery and the segments remaining with the delivery catheter 100 Slide mechanism 140 also includes visual markers 150 that help the physician with operation of the control mechanism 140 Additionally, the slide mechanism 140 may comprise detents or a ratchet that further assists physician operation by providing audible or tactile feedback This seπes of steps is illustrated in Figs 2A-2F and is described in more detail below
[0032] Additional details on materials and construction of other related handles are descπbed in co-pending U S Patent Application No 1 1/148,713, filed June 8, 2005, (Attorney Docket No 14592 4002), entitled "Devices and Methods for Operating and Controlling Interventional Apparatus," and co-pending United States Publication No 2005/0149159, entitled "Devices and Methods for Controlling and Indicating the Length of an Interventional Element,"' the full disclosures of which are incorporated herein by reference
|0033) Both sheath 144 and outer shaft 124 along with guidcwire 138 each extend through a slider assembly 132 slidaby disposed on the catheter body 120 at a point between its handle 106 and expandable member 130. The slider assembly 132 is adapted for insertion into and sealing with a hemostasis valve, such as on an introducer sheath or guiding catheter, while still allowing relative movement of the outer shaft 124 and sheath 144 relative to the slider assembly 132. The slider assembly 132 includes a slider tube 1 18, a slider body 1 16, and a slider cap 1 14.
|0034] Outer shaft 124 and sheath 144 may be composed of any of a variety of biocompatible materials, such as but not limited to a polymer like PTFE, FEP, polyimide, Nylon or Pebax, and may be reinforced with a metallic or polymeric braid to resist radial expansion of inflatable balloon 130, and/or the like. Inflatable balloon 130 may be formed of a semi-compliant polymer such as Pebax, Nylon, polyurethane, polypropylene, PTFE or other suitable polymers. Additional aspects of the luminal prosthesis delivery system are described in U.S. Patent Application Serial No. 10/306,813, filed November 27, 2002 (Attorney Docket No. 021629-000320US); U.S. Patent Application Serial No. 10/637,713, filed August 8, 2003 (Attorney Docket No. 021629-000340US); U.S. Patent Application Serial No. 10/738,666, filed December 16, 2003 (Attorney Docket No. 021629-00051 OUS); U.S. Patent Application Serial No. 1 1/104,305, filed April 1 1 , 2005 (Attorney Docket No. 021629-003300US); and U.S. Application Serial No. 1 1/148,585, filed June 8, 2005, the full disclosures of which are hereby incorporated by reference.
[0035] Delivery catheter 100 also includes a separator or "stent valve"' disposed near the distal end of outer shaft 21 1 and an exemplary embodiment of this is seen in Fig. 2A. In Fig. 2A, outer shaft 21 1 is retracted so that its distal tip is proximal to the proximal-most end of the prosthetic stent segments 202. At the same time, sheath 208 is advanced fully distally, covering the plurality of prosthetic segments 202 which are disposed over expandable member 204. Expandable member 204 acts as a carrier which supports the prosthetic segments 202.
[0036] Separator 206 contacts and engages prosthetic segments 202. As shown in Fig. 2A, separator 206 includes proximally inclined resilient fingers configured to frictionally engage stent segments 202 when sheath 208 has been retracted and prosthetic segments 202 are exposed. Thus, when outer shaft 211 is retracted proximally, the separator 206 engages the prosthetic segments 202, while the separator 206 slides over the prosthetic segments 202 when the segments 202 are covered by sheath 208. The separator 206 may be a polymeric or
metallic material integrally formed with outer shaft 21 1 , or it may be bonded or otherwise mounted to the interior of the outer shaft 21 1. The geometry of separator 206 can also be toroidal with a circular or ovoid cross-section (like an O-ring) or the separator 206 may have another cross-sectional shape such as triangular, trapezoidal, pyramidal, or other shapes as described in embodiments discussed more fully herein below. The separator 206 can be a polymer such as silicone or urethane, sufficiently soft, compliant and resilient to provide frictional engagement with stent segments 202, in some embodiments without damaging any coating deposited thereon, including therapeutic drug coatings. The separator 206 extends radially inwardly a sufficient distance to engage the exterior of stent segments 202 with sufficient force to allow the stent segments not selected for delivery to be retracted proximally with outer shaft 21 1 so as to create a spacing relative to those stent segments selected for delivery. Other exemplary embodiments of separators along with additional aspects of separator 206 are described in U.S. Patent Application Serial No. 10/412,714, filed April 10, 2003 (Attorney Docket No. 021629-000330US); U.S. Patent Application Serial No. 1 1/344,464, filed January 30, 2006 (Attorney Docket No. 021629-003500US); and U.S. Patent Application Serial No. 1 1/469,773, filed September 1 , 2006 (Attorney Docket No. 021629- 004000US), the entire contents of which are incorporated herein by reference.
|0037] Prosthesis 126 is composed of one or more prosthetic segments 128. Prosthetic stent segments 128 are disposed over an inflation balloon 130. Each stent segment is about 2-20 mm in length, more typically about 2-10 mm in length and preferably being about 2-8 mm in length. Usually 2-20, more typically 2-10 and preferably 2-6 stent segments 128 may be positioned axially over the inflation balloon 130 and the inflation balloon 130 has a length suitable to accommodate the number of stent segments. Stent segments 128 may be positioned in direct contact with an adjacent stent segment so that segment ends are interleaved or there may be a spacing between segment ends. When the segments are spaced apart from one another, the spacing is typically between 0.5 mm and 1 mm. Furthermore, the stent segments 128 may be deployed individually or in groups of two or more at a single treatment site within the vessel lumen.
[0038] Prosthetic stent segments 128 are preferably composed of a malleable metal so they may be plastically deformed by inflation balloon 130 as they are radially expanded to a desired diameter in the vessel at the target treatment site. The stent segments 128 may also be composed of an elastic or superelastic shape memory alloy such as Nitinol so that the stent segments 128 self-expand upon release into a vessel by retraction of the sheath 124. In this
case, an inflation balloon 130 is not required but may still be used for predilation of a lesion or augmenting expansion of the self-expanding stent segments (e.g. postdilation or tacking). Other materials such as biocompatible polymers may be used to fabricate prosthetic stent segments and these materials may further include bioabsorbable or bioerodable properties.
[0039] Stent segments 128 may have any of a variety of common constructions, such as but not limited to those described in U.S. Patent Application Serial No. 10/738,666 filed December 16, 2003 (Attorney Docket No. 02169-00051 OUS), which was previously incorporated by reference. Constructions may include for example, closed cell constructions including expansible ovals, ellipses, box structures, expandable diamond structures, etc. In addition, the closed cells may have complex slotted geometries such as H-shaped slots, I-shaped slots, J- shaped slots, etc. Suitable open cell structures include zigzag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Patent Nos.: 6,315,794; 5,980,552; 5,836,964; 5,527,354; 5,421 ,955; 4,886,062; and 4,776,337.
[0040] In preferred embodiments, prosthetic stent segments 128 may be coated, impregnated, infused or otherwise coupled with one or more drugs that inhibit restenosis, such as Rapamycin, Everolimus, Paclitaxel, analogs, prodrugs, or derivatives of the aforementioned, or other suitable agents, preferably carried in a durable or bioerodable polymeric carrier. Alternatively, stent segments 128 may be coated with other types of drugs or therapeutic materials such as antibiotics, thrombolytics, anti-thrombotics, antiinflammatories, cytotoxic agents, anti-proliferative agents, vasodilators, gene therapy agents, radioactive agents, immunosuppressants, chemotherapeutics and/or stem cells. Such materials may be coated over all or a portion of the surface of stent segments 128, or stent segments 128 may have a porous structure or include apertures, holes, channels, or other features in which such materials may be deposited.
[0041] Referring now to Figs. 2A-2F, the deployment of selected prosthetic segments to treat a stenotic lesion is shown in accordance with an exemplary embodiment. While the embodiment will be described in the context of a coronary artery stent procedure, it should be understood that the invention may be employed in any variety of blood vessels and other body lumens in which stents or tubular prostheses are deployed, including the carotid, femoral, iliac and other arteries and vein, as well as non-vascular body lumens, such as the ureter, urethra,
fallopian tubes, the hepatic duct and the like. A guide catheter (not illustrated) is first inserted into a peripheral artery such as the femoral artery, typically using a percutaneous procedure such as the Seldinger technique or by surgical cutdown, and then advanced to the ostium of the right or left coronary artery. Guidewire GW is then inserted through the guiding catheter and advanced to the target vessel V, where the lesion L to be treated is located. The proximal end of guidewire GW is then inserted through nose cone 210, through the catheter shaft 216 and exits guidewire tube 122 (seen in Fig. 1 ) which is outside the patient's body.
[0042] Fig. 2A shows stent delivery catheter 200 slidably advanced over the guidewire GW into the vessel V so that the nosecone 210 is distal to the lesion L. The delivery catheter 200 has an expandable member 204 disposed over a catheter shaft 216 and stent segments 202 having interleaved ends in engagement with each other are disposed over the expandable member 204, which is a balloon in this embodiment. The stent segments 202 are covered by sheath 208. The sheath 208 protects stent segments 202 during delivery and also prevents unintended axial displacement of the segments 202. In this embodiment, six stent segments 202 are disposed on the stent delivery catheter 200, each having a length approximately 6 mm long. Thus, in this embodiment, the delivery catheter 200 is adapted to deliver a prosthesis having a length ranging from 6 mm long, up to 36 mm long in 6 mm increments. Other lengths and quantities of stent segments may be employed and this exemplary embodiment is not meant to limit the scope of the present invention. A separator or stent valve 206 is disposed on the inner surface of outer shaft 21 1 and is adapted to engage prosthetic segments 202 and facilitates their deployment. Additionally, sheath 208 has an annular flange or tab 212 disposed on its outer surface that is adapted to pass through the stent valve 206 during retraction or advancement and to engage the annular flange or tab 214 disposed on the inner surface of outer shaft 21 1.
[0043] The length of the lesion to be treated is typically visualized by introducing contrast media into the target vessel V and observing the resulting image under a fluoroscope. Radiopaque markers 226, 228, one at the distal end of the balloon 204 and one at the distal end of the outer shaft 21 1 may be used to visualize the length of stent segments 202 exposed for deployment relative to the target lesion. This is accomplished by advancing the delivery catheter 200 so that radiopaque marker 226 is at the distal edge of the lesion and then outer shaft 21 1 is advanced until radiopaque marker 228 is at the proximal edge of the lesion. Retraction of sheath 208 engages outer shaft 21 1 and then both sheath 208 and outer shaft 21 1 are retracted distally, resulting in a number of stent segments 218 being selected to match the
length of lesion L, as shown in Fig. 2B. In Fig. 2B, outer shaft 21 1 is advanced distally so as to select two prosthetic segments 218 having a combined length of approximately 12 mm. Additional prosthetic segments 202 may be selected if necessary, although here, four prosthetic segments 202 will remain with the delivery catheter 200. As outer shaft 21 1 is advanced, stent valve 206 is angled inwardly and adapted so that it will slide over sheath 208 without hindering distal motion of outer shaft 21 1. Advancement of outer shaft 21 1 may be controlled by the control mechanism 106 illustrated in Fig. 1 , although other actuators may be employed.
[0044] After an appropriate number of prosthetic segments have been selected for deployment, the selected segments 218 are exposed in preparation for delivery. In Fig. 2C, sheath 208 is retracted proximally and thus the selected prosthetic segments 218 are no longer constrained from expansion. As sheath 208 is retracted, its annular flange 212 slides past the stent valve 206. Retraction of sheath 208 continues until the sheath annular flange 212 engages the outer shaft annular flange 214. The two flanges 212, 214 are designed to provide a positive stop to one another. Thus, continued retraction of sheath 208 results in simultaneous retraction of outer shaft 21 1 , as shown in Fig. 2D. Retraction of sheath 208 can be accomplished using the control mechanism 140 depicted in Fig. 1.
[0045] Additionally, once annular flange 212 on the sheath 208 has passed through stent valve 206, stent valve 206 is no longer disposed over sheath 208. The stent valve 206 now engages the distal-most prosthetic segment 202 in the group of prosthetic segments remaining with the delivery catheter 200, and this is shown in Fig 2D. Stent valve 206 is inclined such that further retraction of sheath 208 not only retracts outer shaft 21 1 , but stent valve 206 also retracts the group of prosthetic segments 202 that remain with the delivery catheter 200, thereby creating a spacing between prosthetic segments 202 remaining with the delivery catheter 200 and the prosthetic segments 218 to be delivered. This spacing is typically between 0.5 mm and 5 mm and is required in order to allow a balloon taper to form during balloon inflation. In addition to the inclined stent valve 206 shown in this embodiment, other stent valves are contemplated, including those disclosed in co-pending application number 1 1/469,773, filed September 1 , 2006 (Attorney Docket No. 021629-004000US), entitled "Custom Length Stent Apparatus," the contents of which have previously been incorporated herein by reference.
[0046] Referring now to Fig. 2E, the selected prosthetic segments 218 are deployed. Expandable member 204, here, a balloon, is inflated with a fluid such as contrast media and/or
saline to achieve an expanded diameter 222. Radial expansion of the balloon 204 to an enlarged diameter 222 correspondingly expands stent segments 218 to an expanded diameter 220 outward against the vessel wall across lesion L. The proximal portion of expandable member 204 is constrained by sheath 208 and radiopaque marker 228, preventing its expansion and deployment of the remaining prosthetic segments 202. After stent segments 220 are deployed, expanded balloon 222 is deflated and removed from the deployed stent segments 220, leaving them in a plastically deformed, expanded configuration in the vessel V, at the site of the lesion, L. This is shown in Fig. 2F. Stent segments 202 remain with the delivery catheter 200 which is then removed and retracted from the vessel V.
[0047] While the exemplary embodiments have been described in some detail for clarity of understanding and by way of example, a variety of additional modifications, adaptations and changes may be clear to those of skill in the art. Hence, the scope of the present invention is limited solely by the appended claims.
Claims
WHAT IS CLAIMED IS
1 An apparatus lor dehvei ing prosthetic segments in a body lumen, the apparatus comprising an elongated flexible member having a pioximal end and a distal end, a plurality of prosthetic segments releasably arranged axially along the elongated flexible member near the distal end, a sheath slidably disposed over at least a portion of the prosthetic segments, an outer shaft slidably disposed over at least a portion of the sheath, and a separator disposed on the outer shaft and biased into engagement with at least one prosthetic segment so that the outer shaft may be retracted to separate a proximal group of prosthetic segments from a distal group of the prosthetic segments which are to be deployed in the body lumen, wherein the sheath is positionable between the separator and the prosthetic segments to selectively disengage the separator from the piosthetic segments
2 An apparatus as in claim 1 , wherein the separator exerts substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally
3 An apparatus as in claim 1 , wherein the sheath is configured to engage the outer shaft such that retraction of the sheath retracts the outer shaft
4 An apparatus as in claim 2, wherein the sheath compπses an annular flange
5 An apparatus as in claim 2, wherein the outer shaft compπses an annular flange
6 An apparatus as in claim 1 , further comprising an expandable member near the distal end of the elongated flexible member
7 An apparatus as in claim 6, wherein the expandable member is a balloon
8 An apparatus as in claim 1 , wherein the prosthetic segments are balloon expandable
9. An apparatus as in claim 1 , wherein the prosthetic segments arc self- expanding.
10. An apparatus as in claim 1 , wherein the plurality of prosthetic segments carry a therapeutic agent adapted to being released therefrom.
1 1. An apparatus as in claim 10, wherein the therapeutic agent comprises an anti-restenosis agent.
12. An apparatus as in claim 1 , wherein the plurality of prosthetic segments have a length in the range from about 2 mm to about 10 mm.
13. An apparatus as in claim 1 , wherein the plurality of prosthetic segments have a length about 3 mm to 6 mm.
14. An apparatus as in claim 1 , wherein each of the plurality of prosthetic segments have two or more lengths.
15. An apparatus as in claim 1 , wherein each of the plurality of prosthetic segments have substantially the same length.
16. An apparatus as in claim 1 , wherein the plurality of prosthetic segments have interleaved ends prior to deployment.
17. An apparatus as in claim 1 , wherein the plurality of prosthetic segments are spaced apart prior to deployment to allow the separator to engage the prosthetic segments at their distal ends.
18. An apparatus as in claim 1 , wherein the separator comprises a plurality of resilient fingers projecting radially inward.
19. An apparatus as in claim 18, wherein at least some of the fingers are inclined so that free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally, but to engage a prosthetic segment when the separator is retracted proximally.
20. An apparatus as in claim 18, wherein at least some of the fingers are composed of metal.
21. An apparatus as in claim 18, wherein at least some of the fingers are composed of a polymer.
22. An apparatus as in claim 19, wherein at least some of the fingers comprise a radiused end substantially matching the curvature of the surface of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segments and the separator as the separator is retracted proximally, while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
23. An apparatus as in claim 19, wherein the separator further comprises a hinge coupled to the fingers to allow the fingers to deflect radially to facilitate passage of the separator over the sheath when the separator is advanced distally.
24. An apparatus as in claim 1 , wherein the separator comprises an annular flange.
25. An apparatus as in claim 24, wherein the annular flange is tapered.
26. An apparatus as in claim 1 , wherein the separator comprises a tapered conical nose.
27. An apparatus as in claim 1 , wherein the separator comprises a plurality of inclined ramps disposed on an inner surface of the outer shaft.
28. An apparatus as in claim 27, wherein the inclined ramps are separated by about 90°.
29. An apparatus as in claim 1, wherein the separator comprises a compliant sharp edge.
30. A method for delivering prosthetic segments to a body lumen, the method comprising: introducing a plurality of prosthetic segments releasably arranged axially along an elongated flexible member, into a body lumen having a lesion with a lesion length at a first treatment site; distally advancing an outer shaft having a separator relative to a selected group of prosthetic segments selected for delivery, the selected group of prosthetic segments having a combined length that matches the lesion length; positioning a sheath disposed between the separator and the prosthetic segments until the separator is allowed to engage the prosthetic segments; retracting the outer shaft so as to create a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongated flexible member; and deploying the selected group of prosthetic segments at the first treatment site.
31. A method as in claim 30, wherein the sheath is configured to engage the outer shaft such that retraction of the sheath retracts the outer shaft.
32. A method as in claim 30, wherein the plurality of prosthetic segments are introduced into a blood vessel.
33. A method as in claim 30, wherein the plurality of prosthetic segments are balloon expandable.
34. A method as in claim 30, wherein the plurality of prosthetic segments are self-expanding.
35. A method as in claim 30, wherein deploying the selected group of prosthetic segments comprises plastically deforming the selected group of prosthetic segments.
36. A method as in claim 35, wherein the selected group of prosthetic segments are plastically deformed with a balloon.
37. A method as in claim 30, wherein the plurality of prosthetic segments carry a therapeutic agent adapted to being released therefrom.
38. A method as in claim 37, wherein the therapeutic agent is an anti- restenosis agent.
39. A method as in claim 30, wherein the plurality of prosthetic segments have a length in the range from about 2 mm to about 10 mm.
40. A method as in as in claim 30, wherein the plurality of prosthetic segments have a length about 3 mm to 6 mm.
41. A method as in claim 30, wherein the plurality of prosthetic segments have interleaved ends prior to deployment.
42. A method as in claim 30, wherein ends of the plurality of prosthetic segments are spaced apart prior to deployment to allow the separator to engage the prosthetic segments at their distal ends.
43. A method as in claim 30, wherein the separator exerts substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally.
44. A method as in claim 30, wherein the separator comprises a plurality of resilient fingers projecting radially inward.
45. A method as in claim 44, wherein at least some of the fingers are inclined so that free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but to engage a prosthetic segment when the separator is retracted proximally.
46 . A method as in claim 45, wherein at least some of the fingers are composed of metal.
47. A method as in claim 45, wherein at least some of the fingers are composed of a polymer.
48. A method as in claim 45, wherein at least some of the fingers comprise a radiused end substantially matching the curvature of the surface of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segments and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
49. A method as in claim 45, wherein the separator further comprises a hinge coupled to the fingers, the fingers deflecting radially outward over the sheath when the separator is advanced distally.
50. A method as in claim 30, wherein the separator comprises an annular flange.
51 . A method as in claim 50, wherein the annular flange is tapered.
52. A method as in claim 30, wherein the separator comprises a tapered conical nose.
53. A method as in claim 30, wherein the separator comprises a plurality of inclined ramps disposed on an inner surface of the outer shaft.
54. A method as in claim 53, wherein the inclined ramps are separated by about 90°.
55. A method as in claim 30, wherein the separator comprises a sharp compliant edge.
56. A method for selectively delivering prosthetic segments to a lesion in a treatment region of a body lumen, the method comprising: advancing a delivery catheter through the body lumen to the treatment region, wherein a plurality of prosthetic segments are disposed axially along the delivery catheter; distally advancing an outer shaft having a separator relative to a selected group of prosthetic segments selected for delivery, the selected group of prosthetic segments having a combined length that matches the lesion; positioning a sheath disposed between the separator and the prosthetic segments until the separator is allowed to engage the prosthetic segments; retracting the outer shaft so as to create a spacing between prosthetic segments in the selected group and one or more prosthetic segments remaining with the elongate flexible member; and inflating a balloon disposed on the delivery catheter so as to deploy the group of prosthetic segments while any remaining prosthetic segments stay with the delivery catheter.
57. A method as in claim 56, wherein the sheath is configured to engage the outer shaft such that retraction of the sheath retracts the outer shaft.
58. A method as in claim 56, wherein the body lumen is a blood vessel.
59. A method as in claim 56, wherein the plurality of prosthetic segments are self-expanding.
60. A method as in claim 56, wherein the plurality of prosthetic segments carry a therapeutic agent adapted to being released therefrom.
61. A method as in claim 60, wherein the therapeutic agent is an anti- restenosis agent.
62. A method as in claim 56, wherein the plurality of prosthetic segments have a length in the range from about 2 mm to about 10 mm.
63. A method as in claim 56, wherein the plurality of prosthetic segments have a length about 3 mm to 6 mm.
64. A method as in claim 56, wherein each of the plurality of prosthetic segments have two or more lengths.
65. A method as in claim 56, wherein each of the plurality of prosthetic segments have substantially the same length.
66. A method as in claim 56, wherein the plurality of prosthetic segments have interleaved ends prior to deployment.
67. A method as in claim 56, wherein ends of the plurality of prosthetic segments are spaced apart prior to deployment to allow the separator to engage the prosthetic segments at their distal ends.
68. A method as in claim 56, wherein the separator exerts substantially greater axial force against the prosthetic segments when the separator is retracted proximally than when the separator is advanced distally.
69. A method as in claim 56, wherein the separator comprises a plurality of resilient fingers projecting radially inward.
70. A method as in claim 69, wherein at least some of the fingers are inclined so that free ends of the fingers point proximally allowing the fingers to pass over the prosthetic segments as the separator is advanced distally but will engage a prosthetic segment when the separator is retracted proximally.
71. A method as in claim 70, wherein at least some of the fingers are composed of metal.
72. A method as in claim 70, wherein at least some of the fingers are composed of a polymer.
73. A method as in claim 70, wherein at least some of the fingers comprise a radiused end substantially matching the curvature of the surface of the prosthetic segments thereby providing greater contact surface so as to facilitate engagement between the prosthetic segments and the separator as the separator is retracted proximally while allowing the separator to pass over the prosthetic segments during distal advancement of the separator.
74. A method as in claim 70, wherein the separator further comprises a hinge coupled to the fingers, the fingers deflecting radially outward over the prosthetic segments when the separator is advanced distally.
75. A method as in claim 56, wherein the separator comprises an annular flange.
76. A method as in claim 75, wherein the annular flange is tapered.
77. A method as in claim 56, wherein the separator comprises a tapered conical nose.
78. A method as in claim 56, wherein the separator comprises a plurality of inclined ramps disposed on an inner surface of an outer shaft.
79. A method as in claim 78, wherein the inclined ramps are separated by about 90°.
80. A method as in claim 56, wherein the separator comprises a sharp compliant edge.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/462,951 US20080269865A1 (en) | 2006-08-07 | 2006-08-07 | Custom Length Stent Apparatus |
US11/462,951 | 2006-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008021779A2 true WO2008021779A2 (en) | 2008-02-21 |
WO2008021779A3 WO2008021779A3 (en) | 2008-11-20 |
Family
ID=39082889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/075248 WO2008021779A2 (en) | 2006-08-07 | 2007-08-06 | Custom length stent apparatus |
Country Status (2)
Country | Link |
---|---|
US (1) | US20080269865A1 (en) |
WO (1) | WO2008021779A2 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0121980D0 (en) | 2001-09-11 | 2001-10-31 | Cathnet Science Holding As | Expandable stent |
US20030135266A1 (en) | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7892273B2 (en) | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US7351255B2 (en) | 2001-12-03 | 2008-04-01 | Xtent, Inc. | Stent delivery apparatus and method |
US7147656B2 (en) | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US8080048B2 (en) * | 2001-12-03 | 2011-12-20 | Xtent, Inc. | Stent delivery for bifurcated vessels |
US7137993B2 (en) | 2001-12-03 | 2006-11-21 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
US20040186551A1 (en) | 2003-01-17 | 2004-09-23 | Xtent, Inc. | Multiple independent nested stent structures and methods for their preparation and deployment |
US7182779B2 (en) | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US7309350B2 (en) | 2001-12-03 | 2007-12-18 | Xtent, Inc. | Apparatus and methods for deployment of vascular prostheses |
US7241308B2 (en) | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US8500792B2 (en) | 2003-09-03 | 2013-08-06 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US20080264102A1 (en) | 2004-02-23 | 2008-10-30 | Bolton Medical, Inc. | Sheath Capture Device for Stent Graft Delivery System and Method for Operating Same |
US11259945B2 (en) | 2003-09-03 | 2022-03-01 | Bolton Medical, Inc. | Dual capture device for stent graft delivery system and method for capturing a stent graft |
US11596537B2 (en) | 2003-09-03 | 2023-03-07 | Bolton Medical, Inc. | Delivery system and method for self-centering a proximal end of a stent graft |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US9198786B2 (en) | 2003-09-03 | 2015-12-01 | Bolton Medical, Inc. | Lumen repair device with capture structure |
US8292943B2 (en) | 2003-09-03 | 2012-10-23 | Bolton Medical, Inc. | Stent graft with longitudinal support member |
US20070198078A1 (en) | 2003-09-03 | 2007-08-23 | Bolton Medical, Inc. | Delivery system and method for self-centering a Proximal end of a stent graft |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050288766A1 (en) | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US8317859B2 (en) | 2004-06-28 | 2012-11-27 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US8027736B2 (en) * | 2005-04-29 | 2011-09-27 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
US7853332B2 (en) | 2005-04-29 | 2010-12-14 | Medtronic, Inc. | Lead electrode for use in an MRI-safe implantable medical device |
JP2009530060A (en) | 2006-03-20 | 2009-08-27 | エックステント・インコーポレーテッド | Apparatus and method for deploying connected prosthetic segments |
US20080051867A1 (en) * | 2006-08-28 | 2008-02-28 | Davila Luis A | Multiple in vivo implant delivery device |
US20080199510A1 (en) | 2007-02-20 | 2008-08-21 | Xtent, Inc. | Thermo-mechanically controlled implants and methods of use |
US8486132B2 (en) | 2007-03-22 | 2013-07-16 | J.W. Medical Systems Ltd. | Devices and methods for controlling expandable prostheses during deployment |
US10022250B2 (en) | 2007-12-12 | 2018-07-17 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
US8128677B2 (en) | 2007-12-12 | 2012-03-06 | Intact Vascular LLC | Device and method for tacking plaque to a blood vessel wall |
US7896911B2 (en) | 2007-12-12 | 2011-03-01 | Innovasc Llc | Device and method for tacking plaque to blood vessel wall |
US10166127B2 (en) | 2007-12-12 | 2019-01-01 | Intact Vascular, Inc. | Endoluminal device and method |
US9101503B2 (en) | 2008-03-06 | 2015-08-11 | J.W. Medical Systems Ltd. | Apparatus having variable strut length and methods of use |
CN107961098A (en) | 2008-06-30 | 2018-04-27 | 波顿医疗公司 | System and method for abdominal aneurvsm |
EP2344068B1 (en) | 2008-09-25 | 2022-10-19 | Advanced Bifurcation Systems Inc. | Partially crimped stent |
US8808347B2 (en) | 2008-09-25 | 2014-08-19 | Advanced Bifurcation Systems, Inc. | Stent alignment during treatment of a bifurcation |
US8828071B2 (en) | 2008-09-25 | 2014-09-09 | Advanced Bifurcation Systems, Inc. | Methods and systems for ostial stenting of a bifurcation |
US11298252B2 (en) | 2008-09-25 | 2022-04-12 | Advanced Bifurcation Systems Inc. | Stent alignment during treatment of a bifurcation |
US8821562B2 (en) | 2008-09-25 | 2014-09-02 | Advanced Bifurcation Systems, Inc. | Partially crimped stent |
AU2010223953B2 (en) | 2009-03-13 | 2014-05-01 | Bolton Medical, Inc. | System and method for deploying an endoluminal prosthesis at a surgical site |
US20110054438A1 (en) * | 2009-08-28 | 2011-03-03 | Webster Mark W I | Stent delivery at a bifurcation, systems and methods |
CN109363807B (en) | 2010-03-24 | 2021-04-02 | 高级分支系统股份有限公司 | System and method for treating a bifurcation |
EP2549958A4 (en) | 2010-03-24 | 2016-09-14 | Advanced Bifurcation Systems Inc | Methods and systems for treating a bifurcation with provisional side branch stenting |
AU2014280976B2 (en) * | 2010-07-08 | 2017-07-06 | Intact Vascular, Inc. | Deployment device for placement of multiple intraluminal surgical staples |
EP2672932B1 (en) | 2011-02-08 | 2018-09-19 | Advanced Bifurcation Systems, Inc. | System for treating a bifurcation with a fully crimped stent |
EP2672925B1 (en) | 2011-02-08 | 2017-05-03 | Advanced Bifurcation Systems, Inc. | Multi-stent and multi-balloon apparatus for treating bifurcations |
US8414528B2 (en) * | 2011-05-27 | 2013-04-09 | Abbott Cardiovascular Systems Inc. | Polymer scaffold sheaths |
US10271973B2 (en) | 2011-06-03 | 2019-04-30 | Intact Vascular, Inc. | Endovascular implant |
US9913741B2 (en) | 2011-07-05 | 2018-03-13 | Cook Medical Technologies Llc | Control handle for self-expandable medical devices |
US9254212B2 (en) * | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US8998970B2 (en) | 2012-04-12 | 2015-04-07 | Bolton Medical, Inc. | Vascular prosthetic delivery device and method of use |
US8897513B2 (en) * | 2012-12-28 | 2014-11-25 | Siemens Aktiengesellschaft | Method of selecting a stent based on stress of a blood vessel |
US9439751B2 (en) | 2013-03-15 | 2016-09-13 | Bolton Medical, Inc. | Hemostasis valve and delivery systems |
US9433520B2 (en) | 2015-01-29 | 2016-09-06 | Intact Vascular, Inc. | Delivery device and method of delivery |
US9375336B1 (en) | 2015-01-29 | 2016-06-28 | Intact Vascular, Inc. | Delivery device and method of delivery |
US10993824B2 (en) | 2016-01-01 | 2021-05-04 | Intact Vascular, Inc. | Delivery device and method of delivery |
US11660218B2 (en) | 2017-07-26 | 2023-05-30 | Intact Vascular, Inc. | Delivery device and method of delivery |
CN112399832A (en) * | 2018-06-08 | 2021-02-23 | 埃夫莫拉尔医疗有限公司 | Absorbable endovascular device that shortens when expanded, creating space for vascular motion |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040093061A1 (en) * | 2001-12-03 | 2004-05-13 | Xtent, Inc. A Delaware Corporation | Apparatus and methods for delivery of multiple distributed stents |
US20040215312A1 (en) * | 2001-12-03 | 2004-10-28 | Xtent, Inc. | Stent delivery apparatus and method |
Family Cites Families (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069825A (en) * | 1976-01-28 | 1978-01-24 | Taichiro Akiyama | Surgical thread and cutting apparatus for the same |
US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
US4580568A (en) * | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US5350395A (en) * | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
US4748982A (en) * | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
US5217495A (en) * | 1989-05-10 | 1993-06-08 | United States Surgical Corporation | Synthetic semiabsorbable composite yarn |
CA2026604A1 (en) * | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
AR246020A1 (en) * | 1990-10-03 | 1994-03-30 | Hector Daniel Barone Juan Carl | A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms. |
DE69118083T2 (en) * | 1990-10-09 | 1996-08-22 | Cook Inc | Percutaneous stent assembly |
CA2060067A1 (en) * | 1991-01-28 | 1992-07-29 | Lilip Lau | Stent delivery system |
US5490837A (en) * | 1991-07-05 | 1996-02-13 | Scimed Life Systems, Inc. | Single operator exchange catheter having a distal catheter shaft section |
US5507771A (en) * | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5336178A (en) * | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
US5480423A (en) * | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
US5607444A (en) * | 1993-12-02 | 1997-03-04 | Advanced Cardiovascular Systems, Inc. | Ostial stent for bifurcations |
SI0821920T2 (en) * | 1994-02-25 | 2006-08-31 | Fischell Robert | Stent |
DE4418336A1 (en) * | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent for widening and holding open receptacles |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
FR2733682B1 (en) * | 1995-05-04 | 1997-10-31 | Dibie Alain | ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR |
US5639274A (en) * | 1995-06-02 | 1997-06-17 | Fischell; Robert E. | Integrated catheter system for balloon angioplasty and stent delivery |
EP0830108B1 (en) * | 1995-06-08 | 2003-09-17 | Ave Galway Limited | Endovascular stent |
JP3467916B2 (en) * | 1995-07-10 | 2003-11-17 | 松下電器産業株式会社 | Transmission / reception method |
US6579305B1 (en) * | 1995-12-07 | 2003-06-17 | Medtronic Ave, Inc. | Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material |
US6878161B2 (en) * | 1996-01-05 | 2005-04-12 | Medtronic Vascular, Inc. | Stent graft loading and deployment device and method |
US5749921A (en) * | 1996-02-20 | 1998-05-12 | Medtronic, Inc. | Apparatus and methods for compression of endoluminal prostheses |
US5879381A (en) * | 1996-03-10 | 1999-03-09 | Terumo Kabushiki Kaisha | Expandable stent for implanting in a body |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
US5709701A (en) * | 1996-05-30 | 1998-01-20 | Parodi; Juan C. | Apparatus for implanting a prothesis within a body passageway |
FR2749500B1 (en) * | 1996-06-06 | 1998-11-20 | Jacques Seguin | DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION |
US7238197B2 (en) * | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
CA2211249C (en) * | 1996-07-24 | 2007-07-17 | Cordis Corporation | Balloon catheter and methods of use |
US5755781A (en) * | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US20030093143A1 (en) * | 1999-03-01 | 2003-05-15 | Yiju Zhao | Medical device having surface depressions containing nitric oxide releasing compound |
US5755776A (en) * | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US6086610A (en) * | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US5899935A (en) * | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
US6056722A (en) * | 1997-09-18 | 2000-05-02 | Iowa-India Investments Company Limited Of Douglas | Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
EP0943300A1 (en) * | 1998-03-17 | 1999-09-22 | Medicorp S.A. | Reversible action endoprosthesis delivery device. |
US6037647A (en) * | 1998-05-08 | 2000-03-14 | Fujitsu Limited | Semiconductor device having an epitaxial substrate and a fabrication process thereof |
US6196995B1 (en) * | 1998-09-30 | 2001-03-06 | Medtronic Ave, Inc. | Reinforced edge exchange catheter |
US6293967B1 (en) * | 1998-10-29 | 2001-09-25 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19855421C2 (en) * | 1998-11-02 | 2001-09-20 | Alcove Surfaces Gmbh | Implant |
US6379365B1 (en) * | 1999-03-29 | 2002-04-30 | Alexis Diaz | Stent delivery catheter system having grooved shaft |
US6258117B1 (en) * | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6375676B1 (en) * | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6290673B1 (en) * | 1999-05-20 | 2001-09-18 | Conor Medsystems, Inc. | Expandable medical device delivery system and method |
DE19938377A1 (en) * | 1999-08-06 | 2001-03-01 | Biotronik Mess & Therapieg | Stent for vascular branching |
US6409753B1 (en) * | 1999-10-26 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible stent |
US6702843B1 (en) * | 2000-04-12 | 2004-03-09 | Scimed Life Systems, Inc. | Stent delivery means with balloon retraction means |
US6569180B1 (en) * | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6555157B1 (en) * | 2000-07-25 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Method for coating an implantable device and system for performing the method |
US6582394B1 (en) * | 2000-11-14 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcated vessels |
US20030097169A1 (en) * | 2001-02-26 | 2003-05-22 | Brucker Gregory G. | Bifurcated stent and delivery system |
US6592549B2 (en) * | 2001-03-14 | 2003-07-15 | Scimed Life Systems, Inc. | Rapid exchange stent delivery system and associated components |
EP1258230A3 (en) * | 2001-03-29 | 2003-12-10 | CardioSafe Ltd | Balloon catheter device |
US6712845B2 (en) * | 2001-04-24 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Coating for a stent and a method of forming the same |
US6676692B2 (en) * | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
SE0101887L (en) * | 2001-05-30 | 2002-12-01 | Jan Otto Solem | Vascular instrument and method |
US6679909B2 (en) * | 2001-07-31 | 2004-01-20 | Advanced Cardiovascular Systems, Inc. | Rapid exchange delivery system for self-expanding stent |
US20030045923A1 (en) * | 2001-08-31 | 2003-03-06 | Mehran Bashiri | Hybrid balloon expandable/self expanding stent |
JP4043216B2 (en) * | 2001-10-30 | 2008-02-06 | オリンパス株式会社 | Stent |
US7682387B2 (en) * | 2002-04-24 | 2010-03-23 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US20030135266A1 (en) * | 2001-12-03 | 2003-07-17 | Xtent, Inc. | Apparatus and methods for delivery of multiple distributed stents |
US7182779B2 (en) * | 2001-12-03 | 2007-02-27 | Xtent, Inc. | Apparatus and methods for positioning prostheses for deployment from a catheter |
US7147656B2 (en) * | 2001-12-03 | 2006-12-12 | Xtent, Inc. | Apparatus and methods for delivery of braided prostheses |
US7892273B2 (en) * | 2001-12-03 | 2011-02-22 | Xtent, Inc. | Custom length stent apparatus |
US20030114919A1 (en) * | 2001-12-10 | 2003-06-19 | Mcquiston Jesse | Polymeric stent with metallic rings |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
US6893417B2 (en) * | 2002-09-20 | 2005-05-17 | Medtronic Vascular, Inc. | Catheter and guide wire exchange system with improved proximal shaft and transition section |
US6994721B2 (en) * | 2002-10-21 | 2006-02-07 | Israel Henry M | Stent assembly |
US7169172B2 (en) * | 2002-11-01 | 2007-01-30 | Counter Clockwise, Inc. | Method and apparatus for caged stent delivery |
US6849084B2 (en) * | 2002-12-31 | 2005-02-01 | Intek Technology L.L.C. | Stent delivery system |
US7314480B2 (en) * | 2003-02-27 | 2008-01-01 | Boston Scientific Scimed, Inc. | Rotating balloon expandable sheath bifurcation delivery |
US7241308B2 (en) * | 2003-06-09 | 2007-07-10 | Xtent, Inc. | Stent deployment systems and methods |
US7744620B2 (en) * | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
US20050080475A1 (en) * | 2003-10-14 | 2005-04-14 | Xtent, Inc. A Delaware Corporation | Stent delivery devices and methods |
US7553324B2 (en) * | 2003-10-14 | 2009-06-30 | Xtent, Inc. | Fixed stent delivery devices and methods |
US7192440B2 (en) * | 2003-10-15 | 2007-03-20 | Xtent, Inc. | Implantable stent delivery devices and methods |
US7220755B2 (en) * | 2003-11-12 | 2007-05-22 | Biosensors International Group, Ltd. | 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same |
US7326236B2 (en) * | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7323006B2 (en) * | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
US20050288766A1 (en) * | 2004-06-28 | 2005-12-29 | Xtent, Inc. | Devices and methods for controlling expandable prostheses during deployment |
US20060069424A1 (en) * | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US20060282149A1 (en) * | 2005-06-08 | 2006-12-14 | Xtent, Inc., A Delaware Corporation | Apparatus and methods for deployment of multiple custom-length prostheses (II) |
-
2006
- 2006-08-07 US US11/462,951 patent/US20080269865A1/en not_active Abandoned
-
2007
- 2007-08-06 WO PCT/US2007/075248 patent/WO2008021779A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040093061A1 (en) * | 2001-12-03 | 2004-05-13 | Xtent, Inc. A Delaware Corporation | Apparatus and methods for delivery of multiple distributed stents |
US20040215312A1 (en) * | 2001-12-03 | 2004-10-28 | Xtent, Inc. | Stent delivery apparatus and method |
Also Published As
Publication number | Publication date |
---|---|
WO2008021779A3 (en) | 2008-11-20 |
US20080269865A1 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080269865A1 (en) | Custom Length Stent Apparatus | |
US7892273B2 (en) | Custom length stent apparatus | |
US9700448B2 (en) | Devices and methods for controlling expandable prostheses during deployment | |
US9339404B2 (en) | Devices and methods for controlling expandable prostheses during deployment | |
JP4671960B2 (en) | Apparatus and method for deploying an artificial blood vessel | |
US7402168B2 (en) | Custom-length stent delivery system with independently operable expansion elements | |
JP5918175B2 (en) | Device for implanting a prosthetic segment in a body cavity | |
US20070156225A1 (en) | Automated control mechanisms and methods for custom length stent apparatus | |
US20090076584A1 (en) | Apparatus and methods for deployment of multiple custom-length prostheses | |
US7192440B2 (en) | Implantable stent delivery devices and methods | |
EP1763326B1 (en) | Apparatus and methods for positioning prostheses for deployment from a catheter | |
US20050080475A1 (en) | Stent delivery devices and methods | |
US20070219613A1 (en) | Apparatus and methods for interlocking stent segments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07800019 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07800019 Country of ref document: EP Kind code of ref document: A2 |